Transforming growth factor β (TGF-β) in Gaucher's disease. Preliminary results in a group of patients and their relatives (carriers and non-carriers);Transforming growth factor β (TGF-β) en la enfermedad de Gaucher. Resultados preliminares en un grupo de enfermos y familiares portadores y no portadores

Medicina Clinica

Volumn 115, Issue 16, 2000, Pages 601-604

  Pérez Calvo, Juan I ^a   Gil, Pablo Iñigo ^b   Giraldo Castellano, Pilar ^c   Torralba Cabeza, Miguel A ^a   Civeira, Fernado ^c   García, Sergio Lara ^b   Pocoví, Miguel ^d  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d NONE

Author keywords

Cytokines; Gaucher's disease; Transforming growth factor

Indexed keywords

BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GAUCHER DISEASE; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; GAUCHER DISEASE; HUMANS; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034638681     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71637-X     Document Type: Article

References (31)

1. 4 ed.). Madrid: Mosby/Doyma Libros, 1995; 1886-1892.
2. Grabowski GA. Gaucher disease. Enzymology, genetics, and treatment. Adv Hum Gen 1993; 21: 377-341.
3. Giraldo P, Pérez Calvo J, Pocovi M, Giralt M. Catacteristicas clinicas de la enfermedad de Gaucher en España. Resultados preliminares de una encuesta nacional. Med Clin (Barc) 1997; 109: 619-622.
4. Lacerda L, Amaral O, Pinto R, Oliviera P, Aerts J, Sa Miranda MC. Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population. Clin Genet 1994; 45: 298-300.
5. Devine EA, Smith M, Arredondo Vega FX, Shafit-Zagardo B, Desnick RJ. Chromosomal localization of the gene for Gaucher disease. Prog Clin Biol Res 1982; 95: 511-534.
6. Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 1989; 4: 87-96.
7. Barranger JA, Ginns El. Glucosyl ceramide lipidose: Gaucher's disease. En: Scriver CR, Beaudet AL, Sly WS, Valle D, editores. The metabolic basis of inherited disease. Nueva York: McGraw Hill Inc., 1989; 1677-1698.
8. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications. Am J Hum Genet 1993; 52: 1094-1101.
9. Van Weely S, Van Leeuwen MB, Jansen IDT, De Brujin MA, Brouwer-Kelde EM, Schram AW et al. Clinical phenotype in relation to properties of mutant glucocerebrosidase in cultured fibroblasts. Biochem Biophys Acta 1991; 1096; 310-311.
10. Torralba MA. Análisis molecular de 20 familias españolas afectadas por la enfermedad de Gaucher. Identificación y caracterización de las mutaciones responsables de la enfermedad y estudio de la relación genotipo/fenotipo mediante mutagénesis dirigida y expresión de las proteínas mutantes en células COS-1. Universidad de Zaragoza. Noviembre, 1999.
11. Aerts H. Biochmical markers of diseae manifestation and therapeutic correction in sera of Gaucher patients. Gaucher Clin Perspect 1994; 2: 12-16.
12. Hollak CEM, Van Weely S, Van Oers MHJ, Aerts JMFG. Marked elevation of palsma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994; 93: 1288-1292.
13. Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CEM et al. Plasma tumor necrosis factor-α (TNF-α) levels in Gaucher's disease. Biochim Biophys Acta 1996; 1317:219-222.
14. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflamatory cytokines and the pathogenesis of Gaucher's diseae: increased release of interleukin-6 and interleukin-10. Q J Med 1997; 90: 19-25.
15. Hollak CEM, Evers L, Aerts JMFG, Vam Oers MHJ. Elevated levels of M-CSF, sCD14 and IL19 in type 1 Gaucher disease. Blood Cells Mol Dis 1997, 23: 301-321.
16. Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A et al. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999; 10: 205-210.
17. Lichtenstein M, Zinram A, Horowitz M. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 1997; 23, 395-401.
18. Border WA, Noble NA. Transforming Growth Factor (beta) in Tissue Fibrosis. N Engl J Med 1994; 331: 1286-1292.
19. Sarria AJ, Giraldo P, Pérez-Calvo JI, Pocovi M. Detection of three rare (G377S, T134P and 1451delAC), and two novel mutations (G195W and Rec[1263del55;1342G>c] in Spanish Gaucher Disease patients. Hum Mutat 1999; 14: 88.
20. Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A et al. Gaucher disease: clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) 1992; 71: 337-353.
21. Gal AE, Pentchev PG, Barranger JA, Dambrosia JM, Brady RO. The distribution of the glucocerebroside in the liver of patients with Gaucher's disease. Anal Biochem 95: 127-132.
22. Gery I, Ziglre JSJ, Brady RO, Barranger JA. Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures. J Clin Invest 1981; 68: 1182-1189.
23. Bovin LF, Fredman P. Mansson JE, Buschard K, Bendtzen K. In vitro production of cytokines is influenced by sulfatide and its precursos galactosylceramide. FEBS Lett 1999, 455: 339-343.
24. Zhou S, Kinzler KW, Vogelstein B. Going mad with Smads. N Engl J Med 1999, 341: 1444-1146.
25. Corssmith E, Hollak C, Endet E, Van Oers M, Sauerwein H, Romijn J. Increased basal glucose production in type 1 Gaucher disease. J Clin Endocrinol Metab 1995; 80: 2653-2657.
26. Lieberman J, Beutler E. Elevation of serum angiotensin-converting enzyme in Gaucher's disease. N Engl J Med 1976; 294: 1442-1444.
27. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams ChS, Charru A et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
28. Wolf G, Mueller E, Stahl RAK, Zitadeh FN. Angiotensin I-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993; 92: 1366-1372.
29. Ruiz-Ortega M, González E, Egido J. Molecular characterization of angiotensin II effects on renal interstitial fibroblasts [resumen]. J Am Soc Nephrol 1995; 6: 909A.
30. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnot PJ, Hutchinson IV. Genotipic variation in the transforming growth factor-β 1 gene. Transplantation 1988; 66: 1014-1020.
31. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-833.